Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs) EQUITY
$164.70
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AMGN Avg Daily Volume: 3,801,500
Last Update: 04/25/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 12.65%
Open: $0.00
Previous Close: $164.70
52 Week Range: $133.64 - $184.21
Oustanding Shares: 735,890,171
Market Cap: 120,053,122,497
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 6 6 5
Moderate Buy 1 1 1 1
Hold 10 9 9 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.28 2.16 2.16 2.28
Latest Dividend: 1.15
Latest Dividend Yield: 2.82%
Dividend Ex-Date: 05/15/17
Price Earnings Ratio: 15.93
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
15.93 15.90 30.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.88% 0.76% 47.83%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.10 0.20 0.07
Net Income 11.30 0.50 0.15
EPS 13.00 0.50 0.15
Earnings for AMGN:
EBITDA 12.03B
Revenue 22.99B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $3.00 $3.11 $12.30 $12.67
Number of Analysts 11 8 13 12
High Estimate $3.17 $3.36 $12.94 $13.66
Low Estimate $2.80 $2.95 $11.84 $12.03
Prior Year $2.90 $2.84 $11.65 $12.30
Growth Rate (Year over Year) 3.29% 9.60% 5.59% 3.03%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Jim Cramer

 | Apr 25, 2017 | 4:56 PM EDT
You think the exchange is overvalued? I don't, and here's why.
RMPIA
By

Jim Cramer

 | Apr 5, 2017 | 12:11 PM EDT
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer sheds light on what's next for Amgen AMGN shares following its downgrade by Jefferies.
RMPIA
By

Jim Cramer

 | Mar 23, 2017 | 3:16 PM EDT
Get your plan in place, but understand that the Republic is not in jeopardy.
RMPIA

updateOppenheimer Healthcare Conf.

Mar 21, 2017 | 7:15 AM EDT
Thomson ONE
Oppenheimer Healthcare Conference (Day 1 of 2) - 03/21/17 - 03/22/17 New York, NY
RMPIA
By

Guy Ortmann

 | Mar 20, 2017 | 1:00 PM EDT
These stocks are showing signs of changing direction.
RMPIA
By

Jim Cramer

 | Mar 17, 2017 | 3:37 PM EDT
Today's session is reminiscent of a pre-Trump day.
RMPIA
By

Jim Cramer

 | Mar 16, 2017 | 12:39 PM EDT
'It'll still go higher.'
RMPIA
By

Jim Cramer

 | Mar 15, 2017 | 1:34 PM EDT
This reversal has been incredible to watch.
RMPIA
By

Doug Kass

 | Mar 13, 2017 | 12:47 PM EDT
Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (XLV) (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. Last year more than $18 billion was redeemed out of the healthcare ETFs, according to Morningstar. However there are some technical signposts that the two-year period of underperformance might be ending, as a basing seems likely. Look at the chart and note the recent higher high.
RMPIA
By

Bret Jensen

 | Mar 10, 2017 | 11:30 AM EST
Why the name is sagging, and what it will take to spur the sector higher.
with the market getting a bit frothy here, we'll add some put protection. this is 2X norma...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.